Đuka Ninković-Baroš, Vesna Gajanin, B. Zrnić, Živorad Gajanin, G. Katalina
{"title":"Comparative analysis of clinical and laboratory parameters of autoimmune and idiopathic chronic urticaria patients","authors":"Đuka Ninković-Baroš, Vesna Gajanin, B. Zrnić, Živorad Gajanin, G. Katalina","doi":"10.5937/scriptamed52-33568","DOIUrl":null,"url":null,"abstract":"Background: According to the cause, chronic urticaria is most frequently divided into autoimmune and idiopathic urticaria. Aim of the paper was to determine the frequency of autoimmune urticaria using autologous serum skin testing and a comparative analysis of chronic idiopathic and chronic autoimmune urticaria by disease course, severity and most common comorbidities. Methods: Analysis covered 64 adult patients of both sexes with chronic urticaria, divided into two groups according to their positivity in autologous serum skin testing (group I with positive test and group II with negative test). General haematological and biochemical parameters, antithyroid antibodies, hepatitis serum markers, Helicobacter pylori and Borrelia burgdorferi antibodies were performed for patients in both groups. First group patients were treated by autologous blood therapy (autohaemotherapy). The analytical statistical tool SPSS (Statistical Product and Service Solutions) version 20 for descriptive statistics and statistical methods was used. The significance level used was p = 0.05. Results: The frequency of positive autologous serum test in total population of patients with chronic urticaria was 43.8 %. The average duration of urticaria was 20 months in both groups. Statistically significant difference was found in weekly scores between the studied groups (p = 0.032) in favour of chronic autoimmune urticaria with a positive autologous serum test. Subjects with chronic autoimmune urticaria had a significantly higher association with autoimmune thyroid diseases. Conclusions: Direct relation was established between the use of autologous blood therapy in patients with autoimmune chronic urticaria and improvement of the clinical picture.","PeriodicalId":33497,"journal":{"name":"Scripta Medica","volume":"66 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scripta Medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/scriptamed52-33568","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: According to the cause, chronic urticaria is most frequently divided into autoimmune and idiopathic urticaria. Aim of the paper was to determine the frequency of autoimmune urticaria using autologous serum skin testing and a comparative analysis of chronic idiopathic and chronic autoimmune urticaria by disease course, severity and most common comorbidities. Methods: Analysis covered 64 adult patients of both sexes with chronic urticaria, divided into two groups according to their positivity in autologous serum skin testing (group I with positive test and group II with negative test). General haematological and biochemical parameters, antithyroid antibodies, hepatitis serum markers, Helicobacter pylori and Borrelia burgdorferi antibodies were performed for patients in both groups. First group patients were treated by autologous blood therapy (autohaemotherapy). The analytical statistical tool SPSS (Statistical Product and Service Solutions) version 20 for descriptive statistics and statistical methods was used. The significance level used was p = 0.05. Results: The frequency of positive autologous serum test in total population of patients with chronic urticaria was 43.8 %. The average duration of urticaria was 20 months in both groups. Statistically significant difference was found in weekly scores between the studied groups (p = 0.032) in favour of chronic autoimmune urticaria with a positive autologous serum test. Subjects with chronic autoimmune urticaria had a significantly higher association with autoimmune thyroid diseases. Conclusions: Direct relation was established between the use of autologous blood therapy in patients with autoimmune chronic urticaria and improvement of the clinical picture.
背景:根据病因,慢性荨麻疹最常分为自身免疫性荨麻疹和特发性荨麻疹。本文的目的是通过自体血清皮肤试验确定自身免疫性荨麻疹的发生频率,并根据病程、严重程度和最常见的合并症对慢性特发性和慢性自身免疫性荨麻疹进行比较分析。方法:对64例成人慢性荨麻疹患者进行分析,根据自体血清皮肤试验阳性情况分为阳性组和阴性组。对两组患者进行血液学和生化指标、抗甲状腺抗体、肝炎血清标志物、幽门螺杆菌和伯氏疏螺旋体抗体检测。第一组患者采用自体血液治疗(autohememotherapy)。使用分析统计工具SPSS (statistical Product and Service Solutions)第20版进行描述性统计和统计方法。使用的显著性水平为p = 0.05。结果:慢性荨麻疹患者自体血清检测阳性率为43.8%。两组患者的平均荨麻疹持续时间为20个月。两组间的周评分差异有统计学意义(p = 0.032),有利于自体血清检测阳性的慢性自身免疫性荨麻疹。慢性自身免疫性荨麻疹患者与自身免疫性甲状腺疾病的相关性显著升高。结论:自体血液治疗自身免疫性慢性荨麻疹与改善临床症状有直接关系。